Minima Stent System
Vascular Stenosis (Coarctation of the Aorta, Pulmonary Artery Stenosis) in neonates and infants
Key Facts
About Renata Medical
Renata Medical is a private, commercial-stage medical device company addressing a critical gap in pediatric cardiology. The company has successfully developed and gained FDA approval for the Minima Stent System, a first-of-its-kind, re-expandable stent tailored for infants as small as 1.5 kg, designed to be dilated to adult sizes as the child grows. Founded in 2015 by executives with experience from Edwards Lifesciences, Renata is led by a team with deep expertise in cardiovascular devices and pediatric cardiology, including Chief Medical Officer Dr. Evan Zahn. The company is positioned in a high-need, niche market with limited competition, having transitioned from development to commercialization and early revenue generation.
View full company profile